A practice-based research network
in the New England and North West region of NSW
The first Covid-19 vaccine developed in the Southern Hemisphere, which was developed by Adelaide-based company Vaxine Pty Ltd, and uses recombinant protein technology is being trialed as a booster by the University of
The pressing demands of COVID have prevented some GPs from contributing to the New England GP Research Network (NEGPRN) in recent years but Tamworth Dr Miriam Grotowski believes there are many advantages to
Research conducted in general practice not only helps health professionals to develop new treatment options for targeted populations. It also gives patients the opportunity to contribute to these solutions. GP and Senior Lecturer
Associate Professor Dr Michelle Guppy from the New England GP Research Network collaborated in developing and delivering an online survey on preparedness, confidence and concerns of general practitioners in the early stages of the
The New England General Practice Research Network (NEGPRN) is a practice-based research network in the New England and North West region of NSW. It has been established to improve patient health outcomes through primary care-based research in general practices in this region. It will build the capacity of community based clinicians to develop, undertake and implement research. The NEGPRN is funded by NSW Regional Health Partners in collaboration with the University of New England and University of Newcastle.
New England residents at risk of, or suffering heart disease, may soon be met with professional nutritional support.
The project, launched by a University of Newcastle professor, aims to reduce the risk all together.
